ML399 is an inhibitor of the menin--?MLL interaction. It acts by demonstrating strong and selective effects in MLL leukemia cells and validating specific mechanism of action.
Uses
ML399 is a Menin-Mixed Lineage Leukemia (MLL) protein-protein interaction inhibitor.
References
[1] Progress towards small molecule inhibitors of the Menin-Mixed Lineage Leukemia (MLL) interaction with in vivo utility
